期刊文献+
共找到2篇文章
< 1 >
每页显示 20 50 100
Support vector classification for SAR of 5-HT3 receptor antagonists 被引量:1
1
作者 杨善升 陆文聪 +1 位作者 纪晓波 陈念贻 《Journal of Shanghai University(English Edition)》 CAS 2006年第4期366-370,共5页
In this work, support vector classification (SVC) algorithm was used to build structure-activity relationship (SAR) model of the 5-hydroxytryptamine type 3 (5-HT3 ) receptor antagonists with 26 compounds. In a b... In this work, support vector classification (SVC) algorithm was used to build structure-activity relationship (SAR) model of the 5-hydroxytryptamine type 3 (5-HT3 ) receptor antagonists with 26 compounds. In a benchmark test, SVC was compared with several techniques of machine learning currently used in the field. The prediction performance of the model was discussed on the basis of the leave-one-out cross-validation. The results show that the accuracy of prediction of SVC model was higher than those of back propagation artificial neural network (BP ANN), K-nearest neighbor (KNN) and Fisher methods. 展开更多
关键词 support vector classification structure-activity relationship CHEMOMETRICS 5-ht3 receptor antagonists.
下载PDF
5-HT_3受体拮抗剂在血液系统恶性肿瘤患者化疗止吐中的应用 被引量:9
2
作者 李娟 罗绍凯 +1 位作者 黎军和 赵莹 《实用肿瘤学杂志》 CAS 2003年第3期224-226,共3页
目的 了解和比较不同的5-HT_3拮抗剂的临床疗效和副作用。方法 化疗前30min用凯特瑞3mg,或用欧必亭5mg,或用奈西雅0.3mg,或用富米汀、或枢丹8mg,加生理盐水静脉推注,用药后观察恶心、呕吐等副作用。结果 凯特瑞的止吐疗效为88.92%,明... 目的 了解和比较不同的5-HT_3拮抗剂的临床疗效和副作用。方法 化疗前30min用凯特瑞3mg,或用欧必亭5mg,或用奈西雅0.3mg,或用富米汀、或枢丹8mg,加生理盐水静脉推注,用药后观察恶心、呕吐等副作用。结果 凯特瑞的止吐疗效为88.92%,明显优于枢丹、富米汀、呕必亭,与奈西雅相当,在副作用方面,凯特瑞、枢丹、富米汀、呕必亭、奈西雅均未见严重副作用,凯特瑞的腹胀发生率比奈西雅、富米汀低。结论 凯特端是一种止吐效果好,作用时间持久,能较好控制急性及延迟呕吐,使用安全的理想止吐药。 展开更多
关键词 血液系统恶性肿瘤 5-ht3受体拮抗剂 化疗 止吐 疗效 临床应用
下载PDF
上一页 1 下一页 到第
使用帮助 返回顶部